AIM ImmunoTech Inc. (AIMID)
OTCMKTS · Delayed Price · Currency is USD
6.70
-1.68 (-20.05%)
At close: Jun 13, 2025

AIM ImmunoTech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
61321234593
Upgrade
Market Cap Growth
-61.67%-39.50%-5.77%-49.92%-51.57%-16.26%
Upgrade
Enterprise Value
690-13-842
Upgrade
Last Close Price
6.7019.8043.9931.1992.00179.00
Upgrade
PS Ratio
40.8375.79105.42160.27334.23571.61
Upgrade
PB Ratio
-1.55-9.742.080.590.791.52
Upgrade
P/TBV Ratio
--2.950.630.831.58
Upgrade
EV/Sales Ratio
42.7153.431.51--256.30
Upgrade
Debt / Equity Ratio
-0.65-2.220.070.020.000.04
Upgrade
Asset Turnover
0.010.010.010.000.000.00
Upgrade
Quick Ratio
0.230.421.6526.3574.1636.41
Upgrade
Current Ratio
0.270.441.6826.6974.6136.58
Upgrade
Return on Equity (ROE)
-3138.91%-388.69%-118.93%-40.79%-32.37%-38.54%
Upgrade
Return on Assets (ROA)
-98.37%-88.30%-66.64%-25.36%-17.44%-21.77%
Upgrade
Return on Capital (ROIC)
-322.63%-196.60%-79.38%-25.85%-17.68%-22.27%
Upgrade
Earnings Yield
-255.12%-134.44%-136.00%-86.05%-42.39%-15.46%
Upgrade
FCF Yield
-208.89%-115.70%-99.87%-71.66%-31.04%-11.15%
Upgrade
Buyback Yield / Dilution
-25.35%-15.30%-1.12%-1.49%-48.67%-774.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.